Welch Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Welch Investments's ABBV Position: Q4 2017 in Review
Welch Investments reduced its AbbVie (ABBV) stake by 5.2% in Q4 2017, selling an estimated $324K and leaving 62,165 shares worth $6.01M. The position accounts for 3.82% of the portfolio, ranked #1.
Welch Investments first reported a position in ABBV in Q4 2016 and has held it in 5 quarters since. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.
- Welch Investments held 62,165 shares of AbbVie worth $6.01M as of Q4 2017.
- Welch Investments sold 3,439 AbbVie shares in Q4 2017, an estimated $324K.
- AbbVie made up 3.82% of Welch Investments's portfolio in Q4 2017, its #1 holding.
- Welch Investments first reported a position in AbbVie in Q4 2016 and has held it in 5 quarters since.
- 2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.
Based on Welch Investments's 13F filing for Q4 2017, filed 30 Jan 2018.